Answers are grounded in this paper and cite their sources.
Lipid-based nanocarriers, such as lipid nanoparticles (LNPs), have been widely used as delivery vehicles for nucleic acids and other therapeutics, yet their conventional architecture of a single spherical compartment imposes fundamental limitations on functionality. Current LNP design requires balancing multiple interdependent properties in the formulation, including encapsulation efficiency, endosomal escape, colloidal stability, and targeting specificity, many of which are intrinsically in tension, thereby constraining the optimal formulation space. To address this challenge, we introduce the first example of lipid bilayer-coated LNPs, where an LNP core is encapsulated within an independently tunable outer lipid bilayer. Single-particle analysis shows that ∼72% of particles adopt this coated architecture. This decoupled architecture allows LNPs to become hierarchically structured assemblies, creating two orthogonal design spaces that enable independent tuning of the particle surface without reformulating the LNP core itself. We show how this decoupled design strategy provides an additional axis for LNP engineering, exemplified by three modifications that would each otherwise require reformulation of the core: colloidal stability without PEG lipids, improved transfection using fusogenic lipids, and surface patterning with antibodies. This platform establishes a foundation for next generation nanocarriers with enhanced performance and expanded design flexibility.
No takes yet. Share an insight, caveat, or question.
Cooke et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: